NCT05071144 Advanced SPinal Innovations With Robotics and Enabling Technology Registry
| NCT ID | NCT05071144 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Boston Children's Hospital |
| Condition | Spine Deformity |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2021-12-13 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2021-12-13 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Creation of a pediatric robotic spine surgery registry will allow for data collection and analysis on the coupled use of robotics and navigation, as well as patient-specific rods in pediatric spine deformity surgery across participating study institutions. Eventually, an educational and informative framework for this technology will be established.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of a spine deformity * Scheduled for surgery using robotics and navigation and/or patient-specific rods * Up to and including 21 years of age * Speak and read English or Spanish Exclusion Criteria: • None
Contact & Investigator
Daniel Hedequist, MD
PRINCIPAL INVESTIGATOR
Boston Children's Hospital
Frequently Asked Questions
Who can join the NCT05071144 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 21 Years, studying Spine Deformity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05071144 currently recruiting?
Yes, NCT05071144 is actively recruiting participants. Contact the research team at Jessica.Tonole@childrens.harvard.edu for enrollment information.
Where is the NCT05071144 trial being conducted?
This trial is being conducted at Los Angeles, United States, Aurora, United States, Atlanta, United States, Boston, United States and 6 additional locations.
Who is sponsoring the NCT05071144 clinical trial?
NCT05071144 is sponsored by Boston Children's Hospital. The principal investigator is Daniel Hedequist, MD at Boston Children's Hospital. The trial plans to enroll 700 participants.